Open AccessLimited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets
Author(s) -
Emily Becker,
Anna Schweda,
Karen A.-M. Ullrich,
Caroline J. Voskens,
Raja Atreya,
Tanja M. Müller,
Imke Atreya,
Markus F. Neurath,
Sebastian Zundler
Publication year - 2022
Publication title -
clinical and translational gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.673
H-Index - 35
ISSN - 2155-384X
DOI - 10.14309/ctg.0000000000000494
Subject(s) - vedolizumab , cd14 , cd19 , inflammatory bowel disease , cd8 , medicine , immunology , integrin , microbiology and biotechnology , antibody , immune system , biology , disease , receptor